Detailed answers about AI BIOENGINEERING SOLUTIONS LTD, including incorporation, status, business activity, and accounts information.
When was AI BIOENGINEERING SOLUTIONS LTD founded?
AI BIOENGINEERING SOLUTIONS LTD was officially incorporated on 10 October 2025 and is registered under company number 16778820. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is AI BIOENGINEERING SOLUTIONS LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of AI BIOENGINEERING SOLUTIONS LTD?
AI BIOENGINEERING SOLUTIONS LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does AI BIOENGINEERING SOLUTIONS LTD do?
AI BIOENGINEERING SOLUTIONS LTD operates in the following sectors: 62020 - Information technology consultancy activities, 72110 - Research and experimental development on biotechnology, 72190 - Other research and experimental development on natural sciences and engineering, 85590 - Other education n.e.c.. These SIC codes provide insight into the company's business activities and industry focus.
What is AI BIOENGINEERING SOLUTIONS LTD's registered address?
The registered office address of AI BIOENGINEERING SOLUTIONS LTD is 203 WEST STREET, FAREHAM, HAMPSHIRE, ENGLAND, PO16 0EN. This is the official address filed with Companies House for legal and statutory correspondence.
Is AI BIOENGINEERING SOLUTIONS LTD financially stable?
Financial accounts for AI BIOENGINEERING SOLUTIONS LTD are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.